PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Uncategorized

The Effectiveness of Kava and Saint John’s Wort for the Treatment of Anxiety and Depression

by Eric W. Dolan
January 14, 2010
Reading Time: 3 mins read
Share on TwitterShare on Facebook

Dr. Sarris and Dr. Kavanagh conducted a systematic review of published research on the use of kava and Saint John’s Wort, which was published in The Journal of Alternative and Complementary Medicine in 2009. The study investigated the efficacy, pharmacology, and safety of kava and Saint John’s Wort as treatments for mood and anxiety disorders.

Kava

Kava (Piper methysticum) is a small leafy shrub that grows in warm, moist climates. “Kava” can also refer to the brew made from the roots of the kava plant.

The plant has traditionally been cultivated for medicinal purposes in the South Pacific because of its sedative effects. Recently, it has become available as an alternative medical treatment for anxiety in the form of kava root extracts, although the leaves are sometimes also used.

After reviewing the evidence from a number of published studies of kava, the authors of this study concluded that kava was an effective treatment for generalized anxiety disorder, but failed to find any studies that supported its effectiveness in alleviating the symptoms of obsessive-compulsive disorder, post-traumatic stress disorder, or specific phobias. Nor did the authors find any published study that supported the use of kava for depressive disorders.

Compared to other pharmaceutical substances, there is relatively little information about the pharmacokinetic effects of kava. The current evidence suggests that kava produces its anti-anxiety effects by interacting with GABA receptors in the hippocampus and amygdala, areas of the brain associated with emotion.

Kava has been banned in Canada, the United Kingdom, and the European Union because of fears that it causes liver damage. As the authors explain, “At least 93 cases of hepatotoxicity [liver damage] have been documented wherein kava may be implicated. Most cases were poorly reported and many involved the concurrent ingestion of pharmaceuticals and alcohol, excessive daily dosage or long-term administration.” Furthermore, the authors suggest that kava should be removed from over-the-counter use so that kava extracts can be standardized and monitored by health professionals.

Because of these concerns, kava should not be used alongside alcohol or by those with liver diseases.

Google News Preferences Add PsyPost to your preferred sources

Saint John’s Wort

Saint John’s Wort (Hypericum perforatum) is a small plant that has been used by both the ancient Greeks and Native Americans for a variety of medical purposes. Currently, extracts of Saint John’s Wort are used as an alternative treatment for depression.

According to Dr. Sarris and Dr. Kavanagh, Saint John’s Wort is “used extensively in Europe as an anti-depressant agent. In Germany [Saint John’s Wort] is one of the most prescribed antidepressant agents, with more than 100 million daily doses.”

The effectiveness of Saint John’s Wort is hotly debated. In their review, Dr. Sarris and Dr. Kavanagh found that in some cases Saint John’s Wort was more effective than synthetic antidepressants, but others believe that this is not the case. One study, the “Hypericum Depression Trial Study Group” published in 2002, found that the use of Saint John’s Wort was not more effective than placebo, but as Dr. Sarris and Dr. Kavanagh note, “What is commonly omitted in discussion of this trial is that it also found that sertaline [brand name Zoloft and Lustral] also had effects comparable to those of placebo.”

Dr. Sarris and Dr. Kavanagh concluded that Saint John’s Wort is an effective treatment of depression, but found little support that it is an effective treatment for other depressive disorders, such as Seasonal Affective Disorder (SAD) or Dysthymic disorder.

Like kava, little is known about the pharmacological effects of Saint John’s Wort. There are a variety of psychoactive substances in Saint John’s Wort (hyperforin, hypericin, etc) that appear to influence the re-uptake of the neurotransmitters serotonin, dopamine and norepinephrine similar to the way synthetic antidepressants such as Paxil and Zoloft work.

Due to the similarity between the effects of Saint John’s Wort and other antidepressants, the combination of Saint John’s Wort with antidepressants can cause dangerous side-effects, such as serotonin syndrome.

Reference:

Sarris, J. & Kavanagh, D.J. (2009). Kava and saint john’s wort: Current evidence for use in mood and anxiety disorders. The Journal of Alternative and Complementary Medicine, Vol 15, No 8: 827-836.

TweetSendScanShareSendPinShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • Long COVID symptoms linked to measurable damage in the brain’s dopamine system
  • Childhood emotional abuse predicts lower romantic relationship satisfaction
  • What if psychopathic behavior stems from a surprisingly basic physical glitch?
  • People judge faces with more visible eye whites as more trustworthy and attractive
  • Trauma survivors process angry expressions differently on a subconscious level

Science of Money

  • Gold, gifts, and getting married: A new look at how commodity prices shape marriage timing
  • It’s not being a woman that hurts your promotion odds. It’s part-time work and caregiving
  • The generative AI apology: better than a human’s, sometimes
  • When employees can’t be themselves at work, they turn on their employer
  • What brain scans reveal about the gender gap in financial risk-taking

Recent

  • Horror soundtracks can make friendly smiles feel eerie and threatening, study finds
  • New research uncovers distinct personality traits among family murder subtypes
  • Occasional magic mushroom use linked to better mental health among alcohol drinkers
  • Infant brain structure predicts future intelligence scores
  • Men experience more positive private thoughts of sexual submission than women, study finds
  • The “ADHD advantage” in entrepreneurship applies mostly to intelligent men, study finds
  • Income inequality heightens status anxiety and self-objectification across genders
  • Men who crave social power are more likely to endorse strict beauty norms for women
  • Brain activity patterns may shape how we remember childhood trauma
  • Dummy pills reveal the hidden power of human expectation in addiction recovery

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc